Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-10-10 | He earned a B.Sc. in Biochemistry/Physiology and a B.Sc. (Honors) in Pharmacology, both from Adelaide University in Adelaide, Australia and a Ph.D. in Biochemistry from Flinders University. |
| 2019-10-25 | "Dr. Anthony Polverino ... joined the Company on February 5, 2018 as a director." ... "The GNC Committee currently consists of Dr. Arbel (Chair), Dr. Polverino and Mr. Taub" ... Director Compensation Table for Fiscal 2018: "Dr. Anthony Polverino ... 23,904" |
| 2020-10-01 | "Dr. Anthony Polverino | 57 | Director"; "The GNC Committee currently consists of Dr. Arbel (Chair), Dr. Polverino and Mr. Taub"; "Dr. Anthony Polverino ... 34,319" in the Director Compensation Table for Fiscal 2019. |
| 2021-11-04 | Dr. Anthony Polverino | 59 | Director ... Dr. Polverino serves on the GNC Committee. ... Pursuant to resolutions of the Board, Dr. Polverino receives ... an annual cash award in the amount of $12,500, paid in biannual installments, and an annual restricted stock award valued at $12,500 on the date of grant. |
| 2022-12-13 | Dr. Anthony Polverino ... Age 60 ... Position Director ... The GNC Committee currently consists of Dr. Arbel (Chair), Dr. Polverino and Mr. Taub ... Director Compensation Table for Fiscal 2021 ... Total ($) 33,905 |
| 2023-11-08 | He earned a B.Sc. in Biochemistry/Physiology and a B.Sc. (Honors) in Pharmacology, both from Adelaide University in Adelaide, Australia and a Ph.D. in Biochemistry from Flinders University, also in Adelaide. |
| 2024-08-16 | "Dr. Anthony Polverino ... Age 61 ... Position Director" ... "The GNC Committee currently consists of Dr. Arbel (Chair), Dr. Polverino and Mr. Naor" |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06